Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through lice... Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals. 더 보기
DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on January 17, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement...
DURHAM, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of...
DURHAM, N.C., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.595 | 16.6433566434 | 3.575 | 4.21 | 3.4301 | 1458857 | 3.83998241 | CS |
4 | 0.54 | 14.8760330579 | 3.63 | 4.21 | 3.12 | 1524444 | 3.53641528 | CS |
12 | 3.17 | 317 | 1 | 4.21 | 0.8101 | 4880701 | 2.67994665 | CS |
26 | 3.2676 | 362.10106383 | 0.9024 | 4.21 | 0.75 | 2377718 | 2.51093713 | CS |
52 | 3.2399 | 348.338888292 | 0.9301 | 4.21 | 0.75 | 1343380 | 2.32721866 | CS |
156 | -1.46 | -25.9325044405 | 5.63 | 6.43 | 0.75 | 1557207 | 2.23904263 | CS |
260 | 2.29 | 121.808510638 | 1.88 | 11.5696 | 0.75 | 1253534 | 3.19271713 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관